Clinical Trial Update: Circulating Tumor Mitochondrial DNA (ct-mtDNA) As a Biomarker for Biliary Tract Cancer Recurrence Surveillance

View source ↗

Summary

A clinical trial is investigating whether circulating tumor mitochondrial DNA can serve as a biomarker to monitor recurrence in biliary tract cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Snippet

Sponsor: Tongji Hospital | Conditions: Biliary Tract Cancer | Status: RECRUITING